Cargando…
Rationale and performances of a data-driven method for computing the duration of pharmacological prescriptions using secondary data sources
The assessment of the duration of pharmacological prescriptions is an important phase in pharmacoepidemiologic studies aiming to investigate persistence, effectiveness or safety of treatments. The Sessa Empirical Estimator (SEE) is a new data-driven method which uses k-means algorithm for computing...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012860/ https://www.ncbi.nlm.nih.gov/pubmed/35428827 http://dx.doi.org/10.1038/s41598-022-10144-9 |
_version_ | 1784687880422031360 |
---|---|
author | Pazzagli, Laura Liang, David Andersen, Morten Linder, Marie Khan, Abdul Rauf Sessa, Maurizio |
author_facet | Pazzagli, Laura Liang, David Andersen, Morten Linder, Marie Khan, Abdul Rauf Sessa, Maurizio |
author_sort | Pazzagli, Laura |
collection | PubMed |
description | The assessment of the duration of pharmacological prescriptions is an important phase in pharmacoepidemiologic studies aiming to investigate persistence, effectiveness or safety of treatments. The Sessa Empirical Estimator (SEE) is a new data-driven method which uses k-means algorithm for computing the duration of pharmacological prescriptions in secondary data sources when this information is missing or incomplete. The SEE was used to compute durations of exposure to pharmacological treatments where simulated and real-world data were used to assess its properties comparing the exposure status extrapolated with the method with the “true” exposure status available in the simulated and real-world data. Finally, the SEE was also compared to a Researcher-Defined Duration (RDD) method. When using simulated data, the SEE showed accuracy of 96% and sensitivity of 96%, while when using real-world data, the method showed sensitivity ranging from 78.0 (nortriptyline) to 95.1% (propafenone). When compared to the RDD, the method had a lower median sensitivity of 2.29% (interquartile range 1.21–4.11%). The SEE showed good properties and may represent a promising tool to assess exposure status when information on treatment duration is not available. |
format | Online Article Text |
id | pubmed-9012860 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-90128602022-04-18 Rationale and performances of a data-driven method for computing the duration of pharmacological prescriptions using secondary data sources Pazzagli, Laura Liang, David Andersen, Morten Linder, Marie Khan, Abdul Rauf Sessa, Maurizio Sci Rep Article The assessment of the duration of pharmacological prescriptions is an important phase in pharmacoepidemiologic studies aiming to investigate persistence, effectiveness or safety of treatments. The Sessa Empirical Estimator (SEE) is a new data-driven method which uses k-means algorithm for computing the duration of pharmacological prescriptions in secondary data sources when this information is missing or incomplete. The SEE was used to compute durations of exposure to pharmacological treatments where simulated and real-world data were used to assess its properties comparing the exposure status extrapolated with the method with the “true” exposure status available in the simulated and real-world data. Finally, the SEE was also compared to a Researcher-Defined Duration (RDD) method. When using simulated data, the SEE showed accuracy of 96% and sensitivity of 96%, while when using real-world data, the method showed sensitivity ranging from 78.0 (nortriptyline) to 95.1% (propafenone). When compared to the RDD, the method had a lower median sensitivity of 2.29% (interquartile range 1.21–4.11%). The SEE showed good properties and may represent a promising tool to assess exposure status when information on treatment duration is not available. Nature Publishing Group UK 2022-04-15 /pmc/articles/PMC9012860/ /pubmed/35428827 http://dx.doi.org/10.1038/s41598-022-10144-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Pazzagli, Laura Liang, David Andersen, Morten Linder, Marie Khan, Abdul Rauf Sessa, Maurizio Rationale and performances of a data-driven method for computing the duration of pharmacological prescriptions using secondary data sources |
title | Rationale and performances of a data-driven method for computing the duration of pharmacological prescriptions using secondary data sources |
title_full | Rationale and performances of a data-driven method for computing the duration of pharmacological prescriptions using secondary data sources |
title_fullStr | Rationale and performances of a data-driven method for computing the duration of pharmacological prescriptions using secondary data sources |
title_full_unstemmed | Rationale and performances of a data-driven method for computing the duration of pharmacological prescriptions using secondary data sources |
title_short | Rationale and performances of a data-driven method for computing the duration of pharmacological prescriptions using secondary data sources |
title_sort | rationale and performances of a data-driven method for computing the duration of pharmacological prescriptions using secondary data sources |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012860/ https://www.ncbi.nlm.nih.gov/pubmed/35428827 http://dx.doi.org/10.1038/s41598-022-10144-9 |
work_keys_str_mv | AT pazzaglilaura rationaleandperformancesofadatadrivenmethodforcomputingthedurationofpharmacologicalprescriptionsusingsecondarydatasources AT liangdavid rationaleandperformancesofadatadrivenmethodforcomputingthedurationofpharmacologicalprescriptionsusingsecondarydatasources AT andersenmorten rationaleandperformancesofadatadrivenmethodforcomputingthedurationofpharmacologicalprescriptionsusingsecondarydatasources AT lindermarie rationaleandperformancesofadatadrivenmethodforcomputingthedurationofpharmacologicalprescriptionsusingsecondarydatasources AT khanabdulrauf rationaleandperformancesofadatadrivenmethodforcomputingthedurationofpharmacologicalprescriptionsusingsecondarydatasources AT sessamaurizio rationaleandperformancesofadatadrivenmethodforcomputingthedurationofpharmacologicalprescriptionsusingsecondarydatasources |